JNK-IN-23
Product Specifications
CAS Number
1007786-48-2
Target
JNK
Related Pathways
MAPK
Bioactivity
JNK-IN-23 (Compound K12) is an inhibitor of JNK. It effectively inhibits the proliferation of MDA-MB-231 cells with a GIC50 of 30 nM. In vivo, JNK-IN-23 blocks metastatic growth of triple-negative breast cancer (TNBC) . Additionally, it suppresses the growth of lung metastases by dual targeting of glutaminase-1 (GLS) and the pyruvate dehydrogenase complex (PDHC) .
Smiles
O=C1N=C(NC=2SC(=C(C12)C)C)C(SC=3N=C4C=CC=CC4=NC3C)C
Molecular Formula
C19H18N4OS2
Molecular Weight
382.5
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2908-100 1x 100 µL
CD68 (Macrophage Marker) (C68/2908R), 0.2mg/mL
Sign In for Pricing
View Details 
BNUM2552-50 1x 50 µL
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL
Sign In for Pricing
View Details